Related Experiment Videos
Discharging patients who are undergoing mechanical circulatory support
S Winowich1, C J Nastala, J M Pristas
1Artificial Heart Program, University of Pittsburgh Medical Center, Pennsylvania 15213-2582, USA.
The Annals of Thoracic Surgery
|January 1, 1996
Summary
Discharging patients with left ventricular assist devices (LVADs) improves quality of life and offers economic benefits. Revising current regulations can enhance discharge capabilities without compromising patient safety.
Area of Science:
- Cardiology
- Medical Engineering
Background:
- Mechanical circulatory support (MCS) using left ventricular assist systems (LVAS) like the Baxter Novacor is a critical therapy.
- Patient discharge during MCS offers potential quality of life and economic benefits.
Observation:
- Six patients supported by the Baxter Novacor LVAS at the University of Pittsburgh Medical Center were discharged.
- Current protocols and regulations present limitations impacting patient and caregiver quality of life.
Findings:
- Discharge from MCS is associated with improved quality of life and economic advantages.
- Regulatory constraints within existing protocols negatively affect patient and caregiver experiences.
Implications:
- Streamlining regulations can improve the feasibility and outcomes of patient discharge during MCS.
- Removing unnecessary regulatory burdens may enhance patient well-being without increasing clinical risks.